Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Korean Circ J. 2003 Mar;33(3):196-204. Korean. Original Article. https://doi.org/10.4070/kcj.2003.33.3.196
Lee SH , Kim DI , Kim JW , Cha KS , Lee SY , Kim SG , Cho KH , Oh JH , Kim W , Kim MH , Kim YD , Ahn TH , Jeong MH , Kim DS , Kang JC , Shin EK , Kim JS .
Cardiology Department, Dong-A University Medical Center, Busan, Korea.
Cardiology Department, Pusan Paik Hospital, Busan, Korea.
Cardiology Department, Ulsan University Hospital, Ulsan, Korea.
Cardiology Department, Masan Samsung Hospital, Masan, Korea.
Heart Center, Gil Medical Center, Incheon, Korea.
Cardiology Department, Chonnam University Hospital, Gwangju, Korea.
Abstract

BACKGROUND AND OBJECTIVES: The optimal treatment for in-stent restenosis(SR) s controversial, although intracoronary radiation therapy(CRT) as provided the most consistent results to date. This study was designed to assess the early and late angiographic results, and to find independent predictors of recurrent restenosis, following cutting balloon angioplasty(BA) or ISR. SUBJECTS AND METHODS: Eighty patients(7 lesions) ith first time ISR underwent CBA and systematic follow-up(U) ngiography. A conventional balloon was used before, or after, the CBA, if required. ICRT was used in 18 lesions(1%). A multivariate logistic regression analysis was performed.(why?) RESULTS: he ISR was focal(n=2, 37%), diffuse or proliferative(n=1, 58%) nd occlusive(n=4, 5%). Procedural success was achieved in all 87 lesions(00%). No significant edge dissection occurred. The pre- and post-procedural diameter stenoses(S) ere 81.5+/-10.8% and 6.7+/-6.0%, respectively, and the pre- and post-procedural MLD(efine MLD?) .71+/-0.44 mm and 2.85+/-0.32mm, respectively, with 2.14+/-0.44mm of acute gain. A FU angiography was performed in 54(8%) f the 69 lesions treated with CBA alone. The overall angiographic restenosis rate was 24%(3/54), with 9%(/22) n the focal ISR and 34%(1/32) n the diffuse or occlusive ISR. The FU DS and MLD were 32.0+/-23.4% and 2.1+/-0.7mm, respectively, with 0.79+/-0.69mm of late loss. The length of a restenotic lesion(R 12.2, 95% CI:1.3-115.2, p=.0286) as an independent predictor of recurrent restenosis. CONCLUSION: CBA is a simple and efficient first line treatment for ISR, with an acceptable restenosis rate, and the length of a restenotic lesion is an independent predictor of recurrent restenosis. In diffuse or occlusive ISR, more definite treatment modalities, such as ICRT combined with CBA or debulking techniques, might be required to reduce recurrent restenosis.

Copyright © 2019. Korean Association of Medical Journal Editors.